The purpose of this study is to study the pharmacokinetics profiles of generic
lopinavir/ritonavir and Pediatric Aluvia® at reduced dose by assessing safety, tolerability
and efficacy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration